Increasing and decreasing phases of ferritin and hemosiderin iron determined by serum ferritin kinetics

Nagoya Journal of Medical Science

Volumn 75, Issue 3-4, 2013, Pages 213-223

  Saito, Hiroshi ^a   Hayashi, Hisao ^b   Tomita, Akihiro ^c   Ohashi, Haruhiko ^d   Maeda, Hideaki ^a   Naoe, Tomoki ^c  

^a Kawamura Hospital   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

Author keywords

Increasing and decreasing phases of iron stores; Iron in chronic hepatitis C.; Recovery of ferritin iron; Serum ferritin kinetics; Transformation of ferritin into hemosiderin

Indexed keywords

FERRITIN; HEMOSIDERIN; IRON;

ARTICLE; BLOOD; HEMOCHROMATOSIS; HEPATITIS C; HUMAN; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; KINETICS; MALE; METABOLISM; MYELODYSPLASTIC SYNDROME; MYELOID METAPLASIA;

ANEMIA, IRON-DEFICIENCY; FERRITINS; HEMOCHROMATOSIS; HEMOSIDERIN; HEPATITIS C, CHRONIC; HUMANS; IRON; IRON OVERLOAD; KINETICS; MALE; MYELODYSPLASTIC SYNDROMES; PRIMARY MYELOFIBROSIS;

EID: 84883231039     PISSN: 00277622     EISSN: 21863326     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Shoden A, Gabrio BW, Finch CA. The relationship between ferritin and hemosiderin in rabbits and man. J Biol Chem, 1953; 204(2): 823-830. ibido: Sturgeon P, Shoden A. Mechanism of iron storage. In: Iron metabolism. pp 121-146. An international symposium sponsored by CIBA at Aix-en-Provence, July 1-5, 1963. Edited by Gross F. Published in 1964 by Springer-Verlag Berlin, Göttingen, Heidelberg.
2. Addison SM, Biemish MR, Hales CN, Hodgkins M, Jacobs A, Llewellin P. An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. J Clin Pathol, 1972; 25(4): 326-329.
3. Saito H, Tomita A, Ohashi H, Maeda H, Hayashi H, Naoe T. Determination of ferritin and hemosiderin iron in patients with normal iron stores and iron overload by serum ferritin kinetics. Nagoya J Med Sci, 2012; 74(1-2): 39-49.
4. Milder MS, Cook JD, Finch CA. Idiopathic hemochromatosis: an interim report. Medicine, 1980, 59(1): 34-49.
5. Prieto J, Barry M, Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver disease. Gastroenterol, 1975, 68(3): 521-533.
6. van Oost BA, van den Beld B, van Ashbeck BS, Marx JJM. Monitoring of intensive phlebotomy therapy in iron overload by serum ferritin assay. Am J Hematol, 1985; 18(1): 7-12.
7. Haskins D, Stevens AR Jr, Finch SC, Finch CA. Iron metabolism; iron stores in man as measured by phlebotomy. J Clin Invest, 1952; 3(6): 543-547.
8. Cook JD, Lipschitz DA, Miles EM, Finch CA. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr, 1974; 27(7): 681-687.
9. Jacobs A, Worwood M. Ferritin in serum. Clinical and biological implications. New Engl J Med, 1975; 292(18): 951-958.
10. Hayashi H, Takikawa T, Nishimura N, Yano T, Isomura T, Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess iron. Am J Gastroenterol, 1994; 89(7): 986-988.
11. Shiono Y, Hayashi H, Wakusawa S, Sanae F, Takikawa T, Yano M, Yoshioka K, Saito H. Body iron stores and iron restoration rate in Japanese patients with chronic hepatitis C as measured during therapeutic iron removal revealed neither increased body iron stores nor effects of C282Y and H63D mutations on iron indices. Nagoya J Med Sci, 2001; 64(1-2): 5-7.
12. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y, Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, Drelichman G, Magnano C, Verissimo M, Athanassiou-Metaxa A, Giardina P, Kourakli-Symeonidis A, Janka-Schaub G, Coates T, Vermylen C, Olivieri N, Thuret I, Opitz H, Ressayre-Djaffer C, Marks P, Alberti D. A phase 3 study of deferasirox (ICL670), a once a daily oral iron chelator, in patients with beta-thalassemia. Blood, 2006; 107(9): 3455-3462.
13. Saito H, Maeda H. Method for determining the amount of blood loss using the storage iron decrease rate as obtained from serum ferritin after intravenous iron therapy. Rinsho Ketsueki (Jpn J Clin Hematol, in Japanese), 2004; 45(11): 1177-1180.
14. Letsky EA, Miller F, Worwood M, Flynn DM. Serum ferritin in children with thalassaemia regularly transfused. J Clin Pathol, 1974; 27(8): 652-655.
15. Saito H. Clinical aspects on total iron-binding capacity (TIBC), unsaturated iron-binding capacity (UIBC) and serum iron (SI) Acta Haematol Jpn, 1978; 41(6): 1277-1284.
16. Matioli GT, Baker RF. Denaturation of ferritin and its relationship with hemosiderin. J Ultrastruct Res, 1963; 8(5-6): 477-490.
17. Miyazaki E, Kato J, Kobune M, Okumura K, Nishitani N, Arosio P, Niitsu Y. Denatured H-ferritin subunit is a major constituent of haemosiderin in the liver of patients with iron overload. Gut, 2002; 50(3): 413-419.
18. Bothwell TH, Bothwell TH, Charlton R, Cook JD, Finch CA. Chapter 6. Idiopathic haemochromatosis. In: Iron Metabolism in man Edited by Bothwell TH, Charlton R, Cook JD, Finch CA. pp. 132-133, 1979, Blackwell Scientific Publications, Oxford, London, Edinburgh, Melbourne.